This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammerschlag, M. R.
Right arrow Articles by Kalman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammerschlag, M. R.
Right arrow Articles by Kalman, B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2000, p. 4274-4276, Vol. 38, No. 11
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Is Chlamydia pneumoniae Present in Brain Lesions of Patients with Multiple Sclerosis?

Margaret R. Hammerschlag,1 Zheng Ke,2 Fengmin Lu,2 Patricia Roblin,1 Jens Boman,3 and Bernadette Kalman2,*

Chlamydia Research Laboratory, Department of Pediatrics, Division of Infectious Diseases, SUNY Health Science Center at Brooklyn, Brooklyn, New York1; Department of Neurology, MCP Hahnemann University, Philadelphia, Pennsylvania2; and Department of Virology, Umeå University, Umeå, Sweden3

Received 11 July 2000/Returned for modification 9 August 2000/Accepted 22 August 2000

We investigated the presence of Chlamydia pneumoniae in 81 normal and pathological specimens obtained from postmortem brain tissues of patients with multiple sclerosis and with other neurological or nonneurological diseases. The assays used included PCR amplification of all DNA samples in the initial study. Culture and a second PCR amplification of the organism in a subset of 19 brain specimens were also performed in two separate laboratories. All results were negative. Thus, this study on a large number of brain tissues suggests that C. pneumoniae is not involved in inflammatory demyelination.


* Corresponding author. Mailing address: Department of Neurology, MS 423, MCP Hahnemann University, 245 North 15th St., Philadelphia, PA 19102. Phone: (215) 762-1898. Fax: (215) 762-3161. E-mail: bernadette.kalman{at}drexel.edu.


Journal of Clinical Microbiology, November 2000, p. 4274-4276, Vol. 38, No. 11
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Parratt, J., Tavendale, R., O'Riordan, J., Parratt, D., Swingler, R. (2008). Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis. Mult Scler 14: 292-299 [Abstract]  
  • Bagos, P G, Nikolopoulos, G, Ioannidis, A (2006). Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler 12: 397-411 [Abstract]  
  • Contini, C, Cultrera, R, Seraceni, S, Castellazzi, M, Granieri, E, Fainardi, E (2004). Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis. Mult Scler 10: 360-369 [Abstract]  
  • Munger, K. L., DeLorenze, G. N., Levin, L. I., Rubertone, M. V., Vogelman, J. H., Peck, C. A., Peeling, R. W., Orentreich, N., Ascherio, A. (2004). A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts. Neurology 62: 1799-1803 [Abstract] [Full Text]  
  • Kaufman, M, Gaydos, C A, Sriram, S, Boman, J, Tondella, M L, Norton, H J (2002). Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results. Mult Scler 8: 289-294 [Abstract]  
  • Tapia, O., Slepenkin, A., Sevrioukov, E., Hamor, K., de la Maza, L. M., Peterson, E. M. (2002). Inclusion Fluorescent-Antibody Test as a Screening Assay for Detection of Antibodies to Chlamydia pneumoniae. CVI 9: 562-567 [Abstract] [Full Text]  
  • Tondella, M. L. C., Talkington, D. F., Holloway, B. P., Dowell, S. F., Cowley, K., Soriano-Gabarro, M., Elkind, M. S., Fields, B. S. (2002). Development and Evaluation of Real-Time PCR-Based Fluorescence Assays for Detection of Chlamydiapneumoniae. J. Clin. Microbiol. 40: 575-583 [Abstract] [Full Text]  
  • Sotgiu, S, Piana, A, Pugliatti, M, Sotgiu, A, Deiana, G A, Sgaramella, E, Muresu, E, Rosati, G (2001). Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls. Mult Scler 7: 371-374 [Abstract]  
  • Numazaki, K., Chibar, S., Boman, J., Sundstrom, P., Roblin, P. M., Hammerschlag, M. R. (2001). Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology 57: 746-746 [Full Text]  
  • Lenz, D. C., Lu, L., Conant, S. B., Wolf, N. A., Gerard, H. C., Whittum-Hudson, J. A., Hudson, A. P., Swanborg, R. H. (2001). A Chlamydia pneumoniae-Specific Peptide Induces Experimental Autoimmune Encephalomyelitis in Rats. J. Immunol. 167: 1803-1808 [Abstract] [Full Text]  
  • Derfuss, T., Gurkov, R., Then Bergh, F., Goebels, N., Hartmann, M., Barz, C., Wilske, B., Autenrieth, I., Wick, M., Hohlfeld, R., Meinl, E. (2001). Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain 124: 1325-1335 [Abstract] [Full Text]  
  • Gaydos, C. A. (2001). Chlamydia pneumoniae and its proposed link to multiple sclerosis: To be or not to be?. Neurology 56: 1126-1127 [Full Text]  
  • Jacobson, S., Cross, A. (2001). Association of Chlamydia pneumoniae and multiple sclerosis: Stage two?. Neurology 56: 1128-1129 [Full Text]  
  • Smieja, M., Mahony, J. B., Goldsmith, C. H., Chong, S., Petrich, A., Chernesky, M. (2001). Replicate PCR Testing and Probit Analysis for Detection and Quantitation of Chlamydia pneumoniae in Clinical Specimens. J. Clin. Microbiol. 39: 1796-1801 [Abstract] [Full Text]